
- Galcanezumab Safe and Effective for Migraine, Improves Symptoms
- Baclofen Discontinuation Rates for MS Spasticity Indicate Need for Alternatives
- Limited Drug Exposure Data Halt Accelerated Approval Attempt for Donanemab
- Spouses of Patients With Cancer Face Increased Risk for Psychiatric Disorders
- Adolescent Sleep Patterns Tied to Later Multiple Sclerosis Risk
- Healthy Lifestyle Lowers Memory Decline, Even for Those With Genetic Risk
- ACP Creates Living Guideline for Interventions During Acute Phase of Major Depression
- Emergency Department Screening Program Can ID Undiagnosed Prediabetes, T2DM
- Cluster Headache More Likely to Be Severe, Debilitating for Women Than Men
- Current, Former Smokers With MS Likely to Experience Depression and Anxiety
- Antibody Oligonucleotide Conjugate Fast Tracked for Facioscapulohumeral Muscular Dystrophy
- Moderna’s mRNA Vaccine Candidate Prevents RSV-Associated Disease in Older Adults
Conference Coverage
MORE MEETINGSClinical Tools
Powered by
Wegovy Gains Approval for Treating Obesity in Adolescents
Visual Impairment Prevalent Among Women Living in Homeless Shelters
Paclitaxel-Eluting Stent for Treating Symptomatic Femoropopliteal PAD
Sulbactam-Durlobactam Gets Priority Review for Acinetobacter Infections
Lifestyle Modification Program Had Similar Outcomes as Mindfulness, Placebo in Treatment-Resistant Depression